Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-10-15 2020-10-15
Drug Identification Number 02393581 02393581
Brand name ACT NABILONE ACT NABILONE
Common or Proper name ACT-NABILONE 0.5 MG CAPS ACT-NABILONE 0.5 MG CAPS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients NABILONE NABILONE
Strength(s) 0.5MG 0.5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-08-21 2020-08-21
Actual discontinuation date 2020-08-21 2020-08-21
Remaining supply date 2020-08-21 2020-08-21
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments Item Discontinued Item Discontinued
Health Canada comments